234 related articles for article (PubMed ID: 32169331)
1. Management of central diabetes insipidus.
Garrahy A; Thompson CJ
Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101385. PubMed ID: 32169331
[TBL] [Abstract][Full Text] [Related]
2. Gestational diabetes insipidus: Diagnosis and management.
Ananthakrishnan S
Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101384. PubMed ID: 32205050
[TBL] [Abstract][Full Text] [Related]
3. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia.
Christ-Crain M; Hoorn EJ; Sherlock M; Thompson CJ; Wass JAH
Eur J Endocrinol; 2020 Jul; 183(1):G9-G15. PubMed ID: 32380474
[TBL] [Abstract][Full Text] [Related]
4. Diabetes insipidus and pregnancy.
Chanson P; Salenave S
Ann Endocrinol (Paris); 2016 Jun; 77(2):135-8. PubMed ID: 27172867
[TBL] [Abstract][Full Text] [Related]
5. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
[TBL] [Abstract][Full Text] [Related]
7. Diabetes insipidus.
Christ-Crain M; Gaisl O
Presse Med; 2021 Dec; 50(4):104093. PubMed ID: 34718110
[TBL] [Abstract][Full Text] [Related]
8. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
9. Acquired forms of central diabetes insipidus: Mechanisms of disease.
Verbalis JG
Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101449. PubMed ID: 32792133
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and Management of Central Diabetes Insipidus in Adults.
Tomkins M; Lawless S; Martin-Grace J; Sherlock M; Thompson CJ
J Clin Endocrinol Metab; 2022 Sep; 107(10):2701-2715. PubMed ID: 35771962
[TBL] [Abstract][Full Text] [Related]
11. Central Diabetes Insipidus in a Preterm Neonate Unresponsive to Intranasal Desmopressin.
Hussain A; Baier RJ; Mehrem AA; Soylu H; Fraser D; Elsayed Y
Neonatal Netw; 2020 Nov; 39(6):339-346. PubMed ID: 33318230
[TBL] [Abstract][Full Text] [Related]
12. Gefitinib Treatment Was Unsuccessful for Central Diabetes Insipidus Due to Pituitary Metastasis of Lung Adenocarcinoma.
Tanaka S; Hirabayashi T; Kimoto M; Hama M; Hachiya T; Gomi K
Intern Med; 2021 Apr; 60(7):1073-1076. PubMed ID: 33162476
[TBL] [Abstract][Full Text] [Related]
13. DDAVP in the treatment of central diabetes insipidus.
Robinson AG
N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
[TBL] [Abstract][Full Text] [Related]
14. 1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus in childhood.
Becker DJ; Foley TP
J Pediatr; 1978 Jun; 92(6):1011-5. PubMed ID: 660339
[TBL] [Abstract][Full Text] [Related]
15. Infection with SARS-CoV-2 may alter the half-life of desmopressin (DDAVP) in patients with central diabetes insipidus.
Dubinski I; Bechtold-Dalla Pozza S; Schmidt H
J Pediatr Endocrinol Metab; 2022 Dec; 35(12):1544-1546. PubMed ID: 36240057
[TBL] [Abstract][Full Text] [Related]
16. DDAVP in the treatment of diabetes insipidus: a clinical study.
Graham JJ; Wise PH; Harding PE
Med J Aust; 1977 Jul; 2(4):113-6. PubMed ID: 895639
[TBL] [Abstract][Full Text] [Related]
17. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
Laczi F; Mezei G; Julesz J; Lázló FA
Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
[TBL] [Abstract][Full Text] [Related]
18. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
Tanae A; Shimizu K; Yoshida S
Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):676-91. PubMed ID: 689212
[TBL] [Abstract][Full Text] [Related]
19. [Long-term treatment of central diabetes insipidus with oral DDAVP].
Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
[TBL] [Abstract][Full Text] [Related]
20. Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: results of a long-term retrospective study.
Behan LA; Sherlock M; Moyles P; Renshaw O; Thompson CJ; Orr C; Holte K; Salehmohamed MR; Glynn N; Tormey W; Thompson CJ
Eur J Endocrinol; 2015 Mar; 172(3):243-50. PubMed ID: 25430399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]